We are live on ! Find out more
JJIJ

Johnson & Johnson Innovation - JJDC Portfolio holdings

AUM $978M
1-Year Est. Return 102.17%
This Fund
S&P 500
This Quarter Est. Return
+99.27%
1 Year Est. Return
+102.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$277M
AUM Growth
–
Cap. Flow
+$228M
Cap. Flow %
82.29%
Top 10 Hldgs %
99.93%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$162M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$24.3M
3
PHGE icon
BiomX
PHGE
+$19.4M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$10M
5
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
+$6.62M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.61%
2 Technology 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$11.8B
$207M 74.59%
+3,260,869
New +$162M
PHGE icon
2
BiomX
PHGE
$1.92M
$20.7M 7.45%
+11,228
New +$19.4M
PTGX icon
3
Protagonist Therapeutics
PTGX
$8.71B
$17.3M 6.23%
+2,449,183
New +$24.3M
PRVB
4
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$16.8M 6.04%
+1,124,973
New +$10M
PHAS
5
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$9.82M 3.54%
+1,607,044
New +$6.62M
ALDX icon
6
Aldeyra Therapeutics
ALDX
$94.7M
$3.46M 1.25%
+594,834
New +$3.44M
CSLT
7
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.08M 0.39%
+811,295
New +$1.13M
SENS icon
8
Senseonics Holdings Inc
SENS
$258M
$481K 0.17%
+26,282
New +$518K
GYRE icon
9
Gyre Therapeutics
GYRE
$666M
$456K 0.16%
+8,927
New +$374K
GNCA
10
DELISTED
Genocea Biosciences, Inc.
GNCA
$298K 0.11%
+143,964
New +$342K
TCON
11
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$197K 0.07%
+4,200
New +$276K

Similar funds

NNP
Nachman Norwood & Parrott Greenville, South Carolina $984M AUM 33.8% 1-Year Est. Return
BAWC
Black-and-white Capital Los Angeles, California $967M AUM 94.03% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
NIA
Northstar Investment Advisors Denver, Colorado $755M AUM 37.8% 1-Year Est. Return
SCM
Snow Capital Management Sewickley, Pennsylvania $703M AUM 76.26% 1-Year Est. Return
EMG
Ellington Management Group Old Greenwich, Connecticut $676M AUM 23.65% 1-Year Est. Return
APA
Allegiant Private Advisors Sarasota, Florida $618M AUM
HFA
Hoover Financial Advisors Malvern, Pennsylvania $562M AUM 37.9% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Johnson & Johnson Innovation - JJDC, which disclosed 11 positions worth $277M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Arrowhead Research: 3,260,869 shares worth $207M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Technology.

  • Johnson & Johnson Innovation - JJDC's largest Q4 2019 buy was Arrowhead Research: 3,260,869 shares worth $207M.
  • Johnson & Johnson Innovation - JJDC's ten largest holdings make up 100% of its $277M portfolio in Q4 2019.
  • Johnson & Johnson Innovation - JJDC disclosed 11 positions in Q4 2019, its first 13F filing on record.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q4 2019, filed 14 Feb 2020.